Anthropic + Gates Aim Claude at HPV and Preeclampsia — May 15, 2026

Anthropic just put two hundred million dollars into AI for diseases pharma forgot.Run time: 21:22In today's episode:Anthropic-Gates put $200M into Claude for neglected diseasesFrontiers in Science manifesto on adaptive surgical robotsNature Medicine asks is AI actually improving careCompanion Nature Medicine piece on meaningful AI evaluationnpj Digital Medicine: RL boosts LLM radiology accuracymedRxiv preprint on AI literacy micro-credentialsClaude for Small Business launches with fifteen workflowsPwC adopts Claude for enterprise deal executionTL;DR:Anthropic and the Gates Foundation announced a four-year, $200M partnership on May 14 — the headline medical pillar is Claude usage credits for research centers hunting drug candidates in HPV and preeclampsia, two indications big pharma has long skipped.Nature Medicine's May issue keeps hammering the same theme it opened the year with: "Is AI actually improving healthcare?" and a companion methodology piece argue static benchmarks are misleading and most deployed medical AI still lacks evidence of attributable clinical benefit.A Frontiers in Science consensus piece from Dasgupta and Granados (King's College London) calls for an entirely new regulatory pathway for adaptive surgical robots that "continue to learn and change after approval" — a direct shot at how FDA and notified bodies currently classify SaMD.Sources cited:Tech StartupsAnthropic newsFrontiers in ScienceNature MedicineNature Medicinenpj Digital MedicinemedRxiv preprintAnthropic newsSubscribe: YouTubemedAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.